连花清瘟胶囊治疗流行性上呼吸道感染的效果研究  

Study on the effect of Lianhua Qingwen capsule in treating epidemic upper respiratory tract infection

作　　者：于璐 YU Lu(Liaoning Health Industry Group Fuxin Mine General Hospital,Fuxin 123000,China)

机构地区：[1]辽宁省健康产业集团阜新矿总医院,123000

出　　处：《中国现代药物应用》2023年第19期92-95,共4页Chinese Journal of Modern Drug Application

摘　　要：目的 观察连花清瘟胶囊治疗流行性上呼吸道感染的效果。方法 240例流行性上呼吸道感染患者,按照不同治疗方式将患者分为对照组和观察组,各120例。对照组接受常规抗病毒口服液治疗,观察组在对照组基础上接受连花清瘟胶囊治疗。比较两组患者临床疗效、不良反应发生情况及治疗后1、2 h体温情况。结果 观察组显效47例(39.17%),有效64例(53.33%),无效9例(7.50%),治疗总有效率为92.50%(111/120);对照组显效42例(35.00%),有效56例(46.67%),无效22例(18.33%),治疗总有效率为81.67%(98/120)。观察组治疗总有效率高于对照组,差异有统计学意义(P<0.05)。观察组不良反应发生率低于对照组,但差异无统计学意义(P>0.05)。观察组治疗后1 h体温为(37.28±0.12)℃,治疗后2 h体温为(36.91±0.10)℃;对照组治疗后1 h体温为(37.89±0.97)℃,治疗后2 h体温为(37.45±0.22)℃。观察组治疗后1、2 h体温均低于对照组,差异有统计学意义(P<0.05)。结论 流行性上呼吸道感染患者接受连花清瘟胶囊治疗可以提升其治疗效果,安全性更好,能改善患者临床症状,降低体温。Objective To observe the effect of Lianhua Qingwen capsule in treating epidemic upper respiratory tract infection.Methods A total of 240 patients with epidemic upper respiratory tract infection were divided into control group and observation group according to different treatment methods,with 120 cases in each group.The control group was treated with conventional antiviral oral liquid treatment,and the observation group was treated with Lianhua Qingwen capsule based on the control group.The clinical efficacy,occurrence of adverse reactions and body temperature at 1 and 2 h after treatment were compared between the two groups.Results In the observation group,47 cases(39.17%)were significantly effective,64 cases(53.33%)were effective and 9 cases(7.50%)were ineffective,with a total effective rate of 92.50%(111/120).In the control group,42 cases(35.00%)were significantly effective,56 cases(46.67%)were effective,22 cases(18.33%)were ineffective,with a total effective rate was 81.67%(98/120).The total effective rate of the observation group was higher than that of the control group,and the difference was statistically significant(P<0.05).The incidence of adverse reactions in the observation group was lower than that in the control group,but the difference was not statistically significant(P>0.05).The body temperature of the observation group was(37.28±0.12)℃at 1 h after treatment,and(36.91±0.10)℃at 2 h after treatment;the body temperature of the control group was(37.89±0.97)℃at 1 h after treatment,and(37.45±0.22)℃at 2 h after treatment.At 1 and 2 h after treatment,the body temperature of the observation group was lower than that of the control group,and the difference was statistically significant(P<0.05).Conclusion Lianhua Qingwen capsule can improve the efficacy,safety,clinical symptoms and lower body temperature of patients with epidemic upper respiratory tract infection.

关 键 词：连花清瘟胶囊 流行性上呼吸道感染 抗病毒口服液 

分 类 号：R259[医药卫生—中西医结合]